CARsgen Therapeutics' market value is the price at which a share of CARsgen Therapeutics trades on a public exchange. It measures the collective expectations of CARsgen Therapeutics Holdings investors about its performance. CARsgen Therapeutics is trading at 2.20 as of the 29th of December 2025. This is a 189.47 percent increase since the beginning of the trading day. The stock's lowest day price was 2.2. With this module, you can estimate the performance of a buy and hold strategy of CARsgen Therapeutics Holdings and determine expected loss or profit from investing in CARsgen Therapeutics over a given investment horizon. Check out CARsgen Therapeutics Correlation, CARsgen Therapeutics Volatility and CARsgen Therapeutics Alpha and Beta module to complement your research on CARsgen Therapeutics.
Please note, there is a significant difference between CARsgen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CARsgen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CARsgen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CARsgen Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to CARsgen Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of CARsgen Therapeutics.
0.00
05/08/2024
No Change 0.00
0.0
In 1 year 7 months and 24 days
12/29/2025
0.00
If you would invest 0.00 in CARsgen Therapeutics on May 8, 2024 and sell it all today you would earn a total of 0.00 from holding CARsgen Therapeutics Holdings or generate 0.0% return on investment in CARsgen Therapeutics over 600 days. CARsgen Therapeutics is related to or competes with Veolia Environnement, Tokyo Steel, BlueScope Steel, Granite Construction, and Tree Island. CARsgen Therapeutics Holdings Limited, a biopharmaceutical company, engages in discovering, developing, and commercializ... More
CARsgen Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure CARsgen Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CARsgen Therapeutics Holdings upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for CARsgen Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as CARsgen Therapeutics' standard deviation. In reality, there are many statistical measures that can use CARsgen Therapeutics historical prices to predict the future CARsgen Therapeutics' volatility.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as CARsgen Therapeutics. Your research has to be compared to or analyzed against CARsgen Therapeutics' peers to derive any actionable benefits. When done correctly, CARsgen Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in CARsgen Therapeutics.
CARsgen Therapeutics Backtested Returns
CARsgen Therapeutics is out of control given 3 months investment horizon. CARsgen Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We have analyze and collected data for eighteen different technical indicators, which can help you to evaluate if expected returns of 2.96% are justified by taking the suggested risk. Use CARsgen Therapeutics Coefficient Of Variation of 812.4, mean deviation of 5.65, and Variance of 543.94 to evaluate company specific risk that cannot be diversified away. CARsgen Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.75, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning CARsgen Therapeutics are expected to decrease at a much lower rate. During the bear market, CARsgen Therapeutics is likely to outperform the market. Use CARsgen Therapeutics information ratio, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to analyze future returns on CARsgen Therapeutics.
Auto-correlation
0.02
Virtually no predictability
CARsgen Therapeutics Holdings has virtually no predictability. Overlapping area represents the amount of predictability between CARsgen Therapeutics time series from 8th of May 2024 to 4th of March 2025 and 4th of March 2025 to 29th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CARsgen Therapeutics price movement. The serial correlation of 0.02 indicates that only 2.0% of current CARsgen Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.02
Spearman Rank Test
0.4
Residual Average
0.0
Price Variance
0.0
CARsgen Therapeutics lagged returns against current returns
Autocorrelation, which is CARsgen Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting CARsgen Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of CARsgen Therapeutics returns to help us make a trade decision. For example, suppose you find that CARsgen Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
CARsgen Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If CARsgen Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if CARsgen Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in CARsgen Therapeutics pink sheet over time.
Current vs Lagged Prices
Timeline
CARsgen Therapeutics Lagged Returns
When evaluating CARsgen Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of CARsgen Therapeutics pink sheet have on its future price. CARsgen Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, CARsgen Therapeutics autocorrelation shows the relationship between CARsgen Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in CARsgen Therapeutics Holdings.
Other Information on Investing in CARsgen Pink Sheet
CARsgen Therapeutics financial ratios help investors to determine whether CARsgen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CARsgen with respect to the benefits of owning CARsgen Therapeutics security.